Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105938![]() (4-{N'-[1-(3,4-Dimethyl-phenyl)-3-ethoxy-5-oxo-1,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50179478![]() (5-((2-(6-(3,4-dimethylphenyl)pyridin-2-yl)-1H-benz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL | Assay Description Agonist activity as induced proliferation in Ba/F3-hTpoR murine lymphocyte expressing human TPOR | Bioorg Med Chem Lett 16: 1212-6 (2006) Article DOI: 10.1016/j.bmcl.2005.11.096 BindingDB Entry DOI: 10.7270/Q2V124BM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105937![]() (3-Hydroxy-4-(10-hydroxy-phenanthren-9-ylazo)-napht...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105939![]() (3-Hydroxy-4-[N'-(3-methyl-5-oxo-1-o-tolyl-1,5-dihy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105940![]() (4-{N'-[1-(3,4-Dimethyl-phenyl)-5-oxo-1,5-dihydro-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105942![]() (4-{N'-[1-(3-tert-Butyl-phenyl)-3-methyl-5-oxo-1,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 70 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105944![]() (3-Hydroxy-4-(2-hydroxy-5-methyl-phenylazo)-naphtha...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | Purchase CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105941![]() (4-(2,3-Dihydroxy-naphthalen-1-ylazo)-3-hydroxy-nap...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105943![]() (4-[N'-(1-Benzyl-3-methyl-5-oxo-1,5-dihydro-pyrazol...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | >3.00E+4 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105947![]() (3-Hydroxy-4-{N'-[3-methyl-5-oxo-1-(3-trifluorometh...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 40 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105946![]() (4-{N'-[1-(3,4-Dimethyl-phenyl)-5-oxo-3-phenyl-1,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 900 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105948![]() (4-{N'-[1-(3-Chloro-phenyl)-3-methyl-5-oxo-1,5-dihy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105949![]() (4-(2,4-Dihydroxy-naphthalen-1-ylazo)-3-hydroxy-nap...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105951![]() (4-(2,6-Dihydroxy-naphthalen-1-ylazo)-3-hydroxy-nap...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105952![]() (4-{N'-[1-(4-Fluoro-phenyl)-3-methyl-5-oxo-1,5-dihy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105945![]() (3-Hydroxy-4-[N'-(3-methyl-5-oxo-1-p-tolyl-1,5-dihy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105956![]() (3-Hydroxy-4-(2-hydroxy-4-sulfo-naphthalen-1-ylazo)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | Purchase CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105953![]() (4-(2,7-Dihydroxy-naphthalen-1-ylazo)-3-hydroxy-nap...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105955![]() (3-Hydroxy-4-{N'-[3-methyl-1-(2-nitro-phenyl)-5-oxo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105954![]() (1-(4-tert-Butyl-phenyl)-4-[(2-hydroxy-4-sulfo-naph...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105959![]() (3-Hydroxy-4-{N'-[3-methyl-1-(4-nitro-phenyl)-5-oxo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 400 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105958![]() (3-Hydroxy-4-[N'-(3-methyl-5-oxo-1-p-tolyl-1,5-dihy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105950![]() (4-{N'-[1-(3,4-Dichloro-phenyl)-3-methyl-5-oxo-1,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105957![]() (4-{N'-[3-Amino-1-(4-tert-butyl-phenyl)-5-oxo-1,5-d...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105962![]() (3-Hydroxy-4-{N'-[1-(4-isopropyl-phenyl)-3-methyl-5...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 70 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105960![]() (3-Hydroxy-4-[N'-(3-methyl-5-oxo-1-m-tolyl-1,5-dihy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 700 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105961![]() (3-Hydroxy-4-(2-hydroxy-7-methoxy-naphthalen-1-ylaz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105964![]() (3-Hydroxy-4-[N'-(3-methyl-5-oxo-1-pyridin-2-yl-1,5...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 7.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105967![]() (3-Hydroxy-4-{N'-[1-(4-iodo-phenyl)-3-methyl-5-oxo-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105965![]() (4-{N'-[1-(3,4-Dimethyl-phenyl)-3-methyl-5-oxo-1,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105966![]() (3-Hydroxy-4-{N'-[3-methyl-5-oxo-1-(4-trifluorometh...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105968![]() (4-{N'-[1-(4-Chloro-phenyl)-3-methyl-5-oxo-1,5-dihy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105969![]() (4-{N'-[1-(4-Benzyloxy-phenyl)-3-methyl-5-oxo-1,5-d...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105972![]() (3-Hydroxy-4-{N'-[3-methyl-1-(3-nitro-phenyl)-5-oxo...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105973![]() (4-{N'-[3-tert-Butyl-1-(3,4-dimethyl-phenyl)-5-oxo-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105970![]() (4-{N'-[1-(4-tert-Butyl-phenyl)-3-methyl-5-oxo-1,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105971![]() (4-{N'-[1-(2-Chloro-phenyl)-3-methyl-5-oxo-1,5-dihy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | >3.00E+4 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105976![]() (3-Hydroxy-4-(1-hydroxy-naphthalen-2-ylazo)-naphtha...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 70 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105974![]() (3-Hydroxy-4-(4-hydroxy-2-methoxy-naphthalen-1-ylaz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105975![]() (3-Hydroxy-4-{N'-[1-(4-methanesulfonyl-phenyl)-3-me...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105977![]() (3-Hydroxy-4-(2-hydroxy-naphthalen-1-ylazo)-naphtha...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105978![]() (4-{N'-[1-(3-Ethylsulfamoyl-phenyl)-3-methyl-5-oxo-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105979![]() (1-(4-tert-Butyl-phenyl)-4-[(2-hydroxy-4-sulfo-naph...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105980![]() (3-Hydroxy-4-[N'-(3-methyl-5-oxo-1-phenyl-1,5-dihyd...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50105963![]() (4-{N'-[1-(3,4-Dimethyl-phenyl)-3-methyl-5-oxo-1,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 40 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Effective concentration for thrombopoietin luciferase activity was determined in BAF-3 cells | J Med Chem 44: 3730-45 (2001) BindingDB Entry DOI: 10.7270/Q2MP52KF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50179469![]() (5-((2-(6-(4-tert-butylphenyl)pyridin-2-yl)-1H-benz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL | Assay Description Agonist activity as induced proliferation in Ba/F3-hTpoR murine lymphocyte expressing human TPOR | Bioorg Med Chem Lett 16: 1212-6 (2006) Article DOI: 10.1016/j.bmcl.2005.11.096 BindingDB Entry DOI: 10.7270/Q2V124BM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50179470![]() (5-((2-(6-(3,4-dichlorophenyl)pyridin-2-yl)-1H-benz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL | Assay Description Agonist activity as induced proliferation in Ba/F3-hTpoR murine lymphocyte expressing human TPOR | Bioorg Med Chem Lett 16: 1212-6 (2006) Article DOI: 10.1016/j.bmcl.2005.11.096 BindingDB Entry DOI: 10.7270/Q2V124BM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50179471![]() (5-[1-[2-(4'-tert-Butyl-2-hydroxy-biphenyl-3-yl)-1H...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL | Assay Description Agonist activity as induced proliferation in Ba/F3-hTpoR murine lymphocyte expressing human TPOR | Bioorg Med Chem Lett 16: 1212-6 (2006) Article DOI: 10.1016/j.bmcl.2005.11.096 BindingDB Entry DOI: 10.7270/Q2V124BM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50179473![]() (2-((2-(6-(4-tert-butylphenyl)pyridin-2-yl)-1H-benz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL | Assay Description Agonist activity as induced proliferation in Ba/F3-hTpoR murine lymphocyte expressing human TPOR | Bioorg Med Chem Lett 16: 1212-6 (2006) Article DOI: 10.1016/j.bmcl.2005.11.096 BindingDB Entry DOI: 10.7270/Q2V124BM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombopoietin receptor (Homo sapiens (Human)) | BDBM50179472![]() (5-((2-(4-(3,4-dimethylphenyl)thiophen-2-yl)-1H-ben...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 780 | n/a | n/a | n/a | n/a |
GlaxoSmithKline Pharmaceuticals Curated by ChEMBL | Assay Description Agonist activity as induced proliferation in Ba/F3-hTpoR murine lymphocyte expressing human TPOR | Bioorg Med Chem Lett 16: 1212-6 (2006) Article DOI: 10.1016/j.bmcl.2005.11.096 BindingDB Entry DOI: 10.7270/Q2V124BM | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 55 total ) | Next | Last >> |